YOYoshihiro Ogawa

Yoshihiro Ogawa

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yoshihiro Ogawa has a total of 91 co-authors. Here are the top co-authors by number of shared publications:

  • Kazuwa Nakao

    21 shared publications
  • Naohisa Tamura

    Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, Kyoto 606-8507, Japan; §Laboratory Animal Research Center, Institute of Medical Science, University of Tokyo, Tokyo 108-0071, Japan; and ¶Suntory Institute for Biomedical Research, 1-1-1 Wakayamadai, Shimamoto-cho, Mishima-gun, Osaka 618-0024, Japan

    10 shared publications
  • Kiminori Hosoda

    6 shared publications
  • Kiyoshi Mori

    Shizuoka General Hospital, Shizuoka 420-8527, Japan

    6 shared publications
  • Hideki Chusho

    Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, Kyoto 606-8507, Japan

    4 shared publications
  • Hiroshi Itoh

    Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, Kyoto 606-8507, Japan; §Laboratory Animal Research Center, Institute of Medical Science, University of Tokyo, Tokyo 108-0071, Japan; and ¶Suntory Institute for Biomedical Research, 1-1-1 Wakayamadai, Shimamoto-cho, Mishima-gun, Osaka 618-0024, Japan

    4 shared publications

Latest Publications

    • 1 September 2004
      • p. 60-4

    [Growth promoting effect of natriuretic peptides on bones formed through endochondral ossification].

    by Akihiro Yasoda, Yasato Komatsu, Kazuwa Nakao, Yoshihiro Ogawa

    • 1 February 2004
      • p. 77-81

    [C-type natriuretic peptide(CNP)--a novel stimulator of bone growth formed through endochondral ossification].

    by Akihiro Yasoda, Yasato Komatsu, Kazuwa Nakao, Yoshihiro Ogawa

    • 1 August 2002
      • p. 79-84

    [Insulin resistant transgenic mice].

    by Ken Ebihara, Yoshihiro Ogawa, Kazuwa Nakao

    • 1 July 2002
      • p. 571-6

    [Leptin and leptin receptor].

    by Yoshihiro Ogawa, Kazuwa Nakao

    • 1 February 2002
      • Vol. 60  (2) , 404-9

    [Obesity induced by abnormality in leptin receptor and melanocortin-4 receptor].

    by Mitsuyo Shintani, Yoshihiro Ogawa, Kazuwa Nakao

    Obesity is a multifactorial disease that arises from complex interactions between genetic predisposition and environmental factors. It increases a risk of cardiovascular and metabolic diseases such as diabetes, hypertension, and hyperlipidemia. Recent molecular genetic studies have disclosed some monogenic forms of obesity in humans. Leptin directly exerts its anorexigenic effects on hypothalamic arcuate nucleus. alpha-melanocyte stimulating hormone (alpha-MSH) derived from proopiomelanocortin (POMC) and melanocortin-4 receptor (MC4-R) have been reported to be involved in the downstream of leptin actions. In this paper, we summarize the clinical characteristics and the mechanisms of obesity caused by genetic abnormalities in leptin receptor and melanocortin-4 receptor.

    • 1 August 2001
      • Vol. 79  (8) , 723-9

    Brain natriuretic peptide appears to act locally as an antifibrotic factor in the heart.

    by Y Ogawa, N Tamura, H Chusho, K Nakao

    In addition to cardiac myocyte hypertrophy, proliferation and increased extracellular matrix production of cardiac fibroblasts occur in response to cardiac overload. This remodeling of the cardiac interstitium is a major determinant of pathologic hypertrophy leading to ventricular dysfunction and heart failure. Atrial and brain natriuretic peptides (ANP and BNP) are cardiac hormones produced primarily by the atrium and ventricle, respectively. Plasma ANP and BNP concentrations are elevated in patients with hypertension, cardiac hypertrophy, and acute myocardial infarction, suggesting their pathophysiologic roles in these disorders. ANP and BNP exhibit diuretic, natriuretic, and vasodilatory activities via a guanylyl cyclase-coupled natriuretic peptide receptor subtype (guanylyl cyclase-A or GC-A). Here we report the generation of mice with targeted disruption of BNP (BNP-/- mice). We observed focal fibrotic lesions in ventricles from BNP-/- mice with a remarkable increase in ventricular mRNA expression of ANP, angiotensin converting enzyme (ACE), transforming growth factor (TGF)-beta3, and pro-alpha1(I) collagen [Col alpha1(I)], which are implicated in the generation and progression of ventricular fibrosis. Electron microscopic examination revealed supercontraction of sarcomeres and disorganized myofibrils in some ventricular myocytes from BNP-/- mice. No signs of cardiac hypertrophy and systemic hypertension were noted in BNP-/- mice. In response to acute cardiac pressure overload induced by aortic constriction, massive fibrotic lesions were found in all the BNP-/- mice examined, accompanied by further increase of mRNA expression of TGF-beta3 and Col alpha1(I). We postulate that BNP acts as a cardiocyte-derived antifibrotic factor in the ventricle.


  • Dwarfism and early death in mice lacking C-type natriuretic peptide

    by Hideki Chusho, Naohisa Tamura, Yoshihiro Ogawa, Akihiro Yasoda, Michio Suda, Takashi Miyazawa, Kenji Nakamura, Kazuki Nakao, Tatsuya Kurihara, Yasato Komatsu, et al.

    Longitudinal bone growth is determined by endochondral ossification that occurs as chondrocytes in the cartilaginous growth plate undergo proliferation, hypertrophy, cell death, and osteoblastic replacement. The natriuretic peptide family consists of three structurally related endogenous ligands, atrial, brain, and C-type natriuretic peptides (ANP, BNP, and CNP), and is thought to be involved in a variety of homeostatic processes. To investigate the physiological significance of CNP in vivo , we generated mice with targeted disruption of CNP ( Nppc −/− mice). The Nppc −/− mice show severe dwarfism as a result of impaired endochondral ossification. They are all viable perinatally, but less than half can survive during postnatal development. The skeletal phenotypes are histologically similar to those seen in patients with achondroplasia, the most common genetic form of human dwarfism. Targeted expression of CNP in the growth plate chondrocytes can rescue the skeletal defect of Nppc −/− mice and allow their prolonged survival. This study demonstrates that CNP acts locally as a positive regulator of endochondral ossification in vivo and suggests its pathophysiological and therapeutic implication in some forms of skeletal dysplasia.


  • Brain natriuretic peptide appears to act locally as an antifibrotic factor in the heart

    by Yoshihiro Ogawa, Naohisa Tamura, Hideki Chusho, Kazuwa Nakao

    In addition to cardiac myocyte hypertrophy, proliferation and increased extracellular matrix production of cardiac fibroblasts occur in response to cardiac overload. This remodeling of the cardiac interstitium is a major determinant of pathologic hypertrophy leading to ventricular dysfunction and heart failure. Atrial and brain natriuretic peptides (ANP and BNP) are cardiac hormones produced primarily by the atrium and ventricle, respectively. Plasma ANP and BNP concentrations are elevated in patients with hypertension, cardiac hypertrophy, and acute myocardial infarction, suggesting their pathophysiologic roles in these disorders. ANP and BNP exhibit diuretic, natriuretic, and vasodilatory activities via a guanylyl cyclase-coupled natriuretic peptide receptor subtype (guanylyl cyclase-A or GC-A). Here we report the generation of mice with targeted disruption of BNP (BNP–/– mice). We observed focal fibrotic lesions in ventricles from BNP–/– mice with a remarkable increase in ventricular mRNA expression of ANP, angiotensin converting enzyme (ACE), transforming growth factor (TGF)-β3, and pro-α1(I) collagen [Col α1(I)], which are implicated in the generation and progression of ventricular fibrosis. Electron microscopic examination revealed supercontraction of sarcomeres and disorganized myofibrils in some ventricular myocytes from BNP–/– mice. No signs of cardiac hypertrophy and systemic hypertension were noted in BNP–/– mice. In response to acute cardiac pressure overload induced by aortic constriction, massive fibrotic lesions were found in all the BNP–/– mice examined, accompanied by further increase of mRNA expression of TGF-β3 and Col α1(I). We postulate that BNP acts as a cardiocyte-derived antifibrotic factor in the ventricle.Key words: atrial natriuretic peptide, brain natiuretic peptide, cardiac fibrosis, guanylyl cyclase.


    • 1 July 2000
      • Vol. 72  (7) , 554-8

    [Transgenic skinny mice overexpressing leptin].

    by Y Ogawa, K Nakao